(Q30407814)

English

Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 June 2017

Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy (English)

1 reference

Europe PubMed Central

21 June 2017

0 references

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

1

object named as

Elena Pariani

1 reference

Europe PubMed Central

21 June 2017

Antonella Amendola

object named as

Antonella Amendola

3

0 references

Alberto Ranghiero

7

object named as

Alberto Ranghiero

1 reference

Europe PubMed Central

21 June 2017

author name string

Antonio Boschini

2

1 reference

Europe PubMed Central

21 June 2017

Raffaella Poletti

4

1 reference

Europe PubMed Central

21 June 2017

Giovanni Anselmi

5

1 reference

Europe PubMed Central

21 June 2017

Marco Begnini

6

1 reference

Europe PubMed Central

21 June 2017

Gianluca Cecconi

8

1 reference

Europe PubMed Central

21 June 2017

Alessandro R Zanetti

9

1 reference

Europe PubMed Central

21 June 2017

language of work or name

0 references

publication date

3 October 2011

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

29

1 reference

Europe PubMed Central

21 June 2017

49

1 reference

Europe PubMed Central

21 June 2017

9209-9213

1 reference

Europe PubMed Central

21 June 2017

Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Pandemic influenza vaccine in adult HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

How common was 2009 pandemic influenza A H1N1?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Response to a monovalent 2009 influenza A (H1N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

A novel influenza A (H1N1) vaccine in various age groups.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.103

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.09.103

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30407814&oldid=1739082253"